WHO approves Sinovac COVID-19 vaccine and Covax vaccines roll off Sinopharm factory lines

SexyChineseLady

Regular Member
Joined
Oct 3, 2016
Messages
956
Likes
542
Country flag
China now has two vaccines approved for Covax -- Sinopharm and Sinovac (the other Covax vaccines are all Western: AZ, Modern, Pfizer, J&J.)



 

SexyChineseLady

Regular Member
Joined
Oct 3, 2016
Messages
956
Likes
542
Country flag
This is why Sinovac got approved! It was able to stop the virus dead in a region that was spiking!


Brazil's Serrana Sees 95% Drop In Covid Cases As All Adults Vaccinated

With 45,000 inhabitants Serrana is a healthy oasis in Brazil, which has the world's second deadliest outbreak.

...

Serrana was the subject of a study by Instituto Butantan, which produces the Coronavac vaccine developed by China's Sinovac Biotech in Brazil.

...
The number of symptomatic cases fell 80%, and hospitalizations 86%. COVID deaths fell 95%, according to data given by Butantan to TV Globo.

Serrana is surrounded by cities that are still dealing with a spike in COVID cases. Ribeirao Preto, 15 miles away from Serrana, is going through a lockdown to try to contain the spread of COVID-19.
 

lcafanboy

Senior Member
Joined
Mar 24, 2013
Messages
3,828
Likes
14,494
Country flag
China now has two vaccines approved for Covax -- Sinopharm and Sinovac (the other Covax vaccines are all Western: AZ, Modern, Pfizer, J&J.)



#CKMKB....

Another Virus H10N3 : China Reports first-ever case of Avian Influenza in Humans, the Disease was limited to Birds until Now..


China needs Thrashing for releasing Bioweapons. Cutler bastard has struck again with a new Bird Flu virus which has spread in humans....😡😡😡

Dirty Chinese whore Fk off...
#CKMKB....
 

SexyChineseLady

Regular Member
Joined
Oct 3, 2016
Messages
956
Likes
542
Country flag
China is helping Pakistan produce millions vaccine doses as well!


ISLAMABAD (Dunya News) – Day after the government decided to run massive COVID vaccination drive across the country to achieve the target of providing 70 million vaccines to the people, Pakistan on Tuesday launched its locally-developed Covid-19 vaccine ‘PakVac’.

PakVac vaccine has been manufactured by the Ministry of Health with the help of China’s Cansino Bio after rigorous quality control checks.
 

Waanar

Senior Member
Joined
Sep 4, 2019
Messages
1,573
Likes
7,456
Country flag
China now has two vaccines approved for Covax -- Sinopharm and Sinovac (the other Covax vaccines are all Western: AZ, Modern, Pfizer, J&J.)



WHO is as credible as a pig on hygiene.
 

johnq

Senior Member
Joined
May 30, 2009
Messages
2,128
Likes
4,254
China's Sinovac COVID-19 Vaccine With 50% Efficacy Rate Gets WHO Approval
WHO
China's Sinovac COVID-19 vaccine, with an efficacy rate of 50 percent, was approved by the World Health Organization (WHO) on Tuesday for emergency use in adults 18 and older.
Data reviewed by WHO experts showed that two doses of the Sinovac vaccine prevented half of those who received the jabs from getting COVID-19, the Associated Press reported. Sinovac's authorization is the second approval by the WHO for a Chinese vaccine following China' Sinopharm shot approval last month.
"Nevertheless, WHO is not recommending an upper age limit for the vaccine," the WHO said in a statement on Sinovac's authorization. Since fewer older adults participated in the research the agency reviewed, they could not estimate the vaccine's efficacy for those over 60.
WHO added that research on Sinovac's use in other countries "suggest the vaccine is likely to have a protective effect in older persons." In April, Brazilian scientists published a study that showed Sinopharm had an efficacy rate over 50 percent while a study in Chile found the vaccine had an efficacy rate of 67 percent.
Just further proof that the W.H.O. is in bed with the Chinese Communist Party, approving a vaccine with 50 percent effectiveness, and that doesn't even include the new variants. :rofl:
 

johnq

Senior Member
Joined
May 30, 2009
Messages
2,128
Likes
4,254
Data just in from Brazil shows the Chinese Covid-19 vaccine to be far less effective than claimed by Beijing, raising serious questions about the Thai government’s decision to invest heavily in the Sinovac jab, with the first doses due to arrive in February.

According to the Brazil-based Butantan Institute, a late-stage trial showed that the efficacy rate of the vaccine was around 50.4 per cent, much lower than the rates needed to establish and maintain herd immunity in a given population.
The silver lining was that the virus was effective in lowering the number of serious cases of Covid-19.

The new verified results from Brazil raises serious questions over the Thai government’s purchasing of 2 million doses of the vaccine and draws into question the government’s relationship with the Chinese government.

Did the Prayut Chan-ocha administration and Anuthin Charnvirakul, the Minister of Public Health, do any research about the vaccine before the purchase agreement was made?

Did they readily accept the results from the Chinese company/government without batting an eyelid?

If the latter is true, then the symbiotic relationship between the military-backed government in Thailand and the Chinese communist party has now taken precedence over the well-being of the Thai people.

According to Prayut and Anuthin, the Sinovacs vaccine was going to be administered to frontline workers – those risking their lives to protect the population from the pandemic. Rather than spending more money to ensure that the vaccine we are giving doctors and nurses is effective, we are giving them a vaccine that is only effective half of the time.

Why? Because the government, specifically those in charge, needs to suck up to their Chinese paymasters to stay in their good graces.

That is why we have Chinese submarines instead of German ones, the reason we have Chinese high speed rail systems instead of Japanese, the reason we turn a blind eye when the people of the Northeast suffer from drought when Chinese dams stop letting out water and now the reason why our frontline workers have a less than effective vaccine.

All of this stems from the government’s insecurity at how they came into power. Prayut and his government needed Beijing’s approval when they came into power because no western government would recognize an administration put in place by a military coup.

As a result, they are indebted to Beijing, indebted to Chinese capital and prestige, even at the expense of their own people.

Let us remember that the PRC is not the benevolent, benign power that it claims to be. One merely has to look at the havoc Beijing has wrought in the domestic economics of Laos and Cambodia to understand that a handshake with Xi Jinping’s government could result in debt-traps and binding contracts that could hamper a country’s economy for decades. Let us not even mention the human rights violations in Xinjiang, Inner Mongolia and Tibet that Beijing is guilty of.

Thailand has spent the last three centuries balancing the hegemony of great powers for our own advantage. It is the most remarkable foreign policy achievement for an otherwise unremarkable regional player.

Yet, the good work of our predecessors stands to be undone by Prayut and his cronies. Rather than continue to pursue the balance of power, this government has chosen instead to side with a dictatorial regime that grows more aggressive and imperialist by the day. If that is indeed the case, then this vaccine is just the first of many bitter pills that we will have to swallow.
 

SexyChineseLady

Regular Member
Joined
Oct 3, 2016
Messages
956
Likes
542
Country flag
That article is SO old :)

These are from today! Sinovac is getting rave reviews! China is exporting close a billion shots :)




 

johnq

Senior Member
Joined
May 30, 2009
Messages
2,128
Likes
4,254
Is that why Brazil is in the middle of a massive pandemic wave of infections? The truth is that the Chinese Communist Party can push a lot of paid articles in the media, all to profit from the pandemic that it intentionally created and spread to the world. But the actual truth cannot be hidden:
China admits to ineffective vaccines, looks to other options

In a rare admission this weekend, the director of China's health agency said COVID vaccines produced by private and state-run groups are not very effective. This comes as an Oregon congressman pushes for effective vaccine property rights be shared to more quickly end the coronavirus pandemic.

The Associated Press reports the director of the China Centers for Disease Control, Gao Fu, said Chinese vaccines “don’t have very high protection rates.”

Sinovac is a private company producing COVID vaccines. Sinopharm is another state-owned firm. International testing has revealed both vaccines are about 50% effective in preventing moderate to severe COVID symptoms.
 

johnq

Senior Member
Joined
May 30, 2009
Messages
2,128
Likes
4,254
Republican accuses China of 'worst cover-up in human history'
CNN's Jake Tapper speaks to Texas Rep. Michael McCaul, a top Republican on the House Foreign Affairs Committee, about the origins of Covid-19, the potential evacuation of thousands of Afghan nationals whose work for the US could make them Taliban targets, and election reforms in his home state.
 

johnq

Senior Member
Joined
May 30, 2009
Messages
2,128
Likes
4,254
This show Chinese Communist Party's power and reach as well as their ability to pressure western media/online outlets.
China Virologist was wiped from the internet for telling the truth: Dr. Li-Meng Yan speaks out
Dr. Li-Meng Yan speaks out to Newsmax after new 'revelations' in investigations into the origins of the worldwide pandemic, researchers from China and aa complete reversal in the American media's coverage of this story. - via The Benny Report with Benny Johnson, Saturdays at 9:30PM ET on Newsmax.
 

johnq

Senior Member
Joined
May 30, 2009
Messages
2,128
Likes
4,254
Chinese virologist Li-Meng Yan speaks to WION's Palki Sharma Upadhyay | Wuhan Whistleblower | WION
Watch the exclusive interview with Chinese virologist Dr Li-Meng Yan.

Basically Chinese Communist Party created the Covid virus in the lab, released it to the world intentionally, and is now profiting by selling its crappy vaccines after disabling countries with more effective vaccines.
 
Last edited:

johnq

Senior Member
Joined
May 30, 2009
Messages
2,128
Likes
4,254
China’s Dangerous Game Around Covid-19 Vaccines
One year after the Covid-19 virus was first identified in Wuhan, China has gone from being the world’s epicenter of the pandemic to one of the countries with the lowest reported infection rates. But alongside this transformation is the Chinese government’s lack of transparency, and its reliance on censorship and propaganda.

The pandemic started with Beijing withholding information from the public, underreporting cases of infection, downplaying the severity of the infection, and dismissing the likelihood of person-to-person spread. Now, the authorities have moved to detain vaccine safety advocates, censor information critical of the Chinese-made vaccines, and spread disinformation about non-Chinese vaccines.

Beijing’s Covid-19 vaccine funding and development process has been shrouded in opacity. While other governments, notably the US and the European Commission, have begun publishing redacted copies of the contracts they have signed with vaccine producers, Chinese authorities have yet to take this step.

More than a dozen Covid-19 vaccines developed in China are in clinical trials, with about half of them in phase 3 trials, which are large-scale studies to assess the vaccine’s level of protection. At the time of writing, only one Chinese vaccine has received emergency approval from what WHO identifies as a “stringent” regulatory authority. None of the vaccines have received full regulatory approval or released phase 3 trial data. Despite this, widespread vaccinations are being administered to the Chinese public as part of a national emergency-use protocol.

As early as July 2020, Chinese authorities began to vaccinate people in “high risk” professions, including medical professionals and border workers. Some state-owned companies required their overseas-based Chinese workers to be vaccinated before they returned to their jobs abroad. Some workers expressed concerns over the lack of transparency and dearth of safety and efficacy data before the vaccine’s official approval.

In recent years, recurring vaccine scandals in the country and the authorities' persistent failure to properly regulate the vaccine market have greatly frustrated the public. Some families of victims of faulty vaccines have for years demanded accountability and have been met with police harassment, intimidation, and even imprisonment.

In October, the authorities in Henan province forcibly disappeared He Fangmei, an outspoken critic of Chinese vaccine companies following her daughter’s diagnosis with a neurological disease after she received vaccinations. He, who was pregnant at the time of her disappearance, has not been heard from since. In January, shortly before WHO experts arrived in China to investigate the origin of Covid-19, Shanghai authorities also forcibly disappeared Hua Xiuzhen, a vaccine safety advocate whose adult daughter developed a neurological disorder after receiving a rabies vaccine in 2014.

In 2018, a court in Henan province sentenced vaccine safety activist Zhang Da’e to two years in prison for “picking quarrels and provoking trouble.” After being given a vaccine at the local government-run epidemic prevention center in Henan province, Zhang’s granddaughter was diagnosed with a brain injury and other illnesses. Though Human Rights Watch is unable to verify the causes of these illnesses, the families all believe they are a result of faulty vaccines.

While there have not been publicly known cases of recipients of the Chinese Covid-19 vaccines suffering severe side effects, the authorities censored online posts raising questions about the safety of the vaccines. A person whose article on WeChat raising such questions was removed lamented on Twitter: “When writing it, I was doing my best to be deliberately vague…in order to pass the censors… As the vaccines began to be rolled out in recent days, clearly felt the atmosphere becoming much more tense.”

As wealthy nations have reserved most of the Western-developed vaccine doses expected to be produced this year, China has offered to fill the demand from developing countries desperate to halt the pandemic. Two major biotech companies, the state-owned Sinopharm and privately owned Sinovac, have sold abroad or received international orders for more than 800 million doses.

At the same time that President Xi Jinping urged nations to “come together against global challenges” and “international cooperation on Covid vaccines,” however, Beijing has mounted an aggressive disinformation campaign inside and outside of the country to sow doubt about Western-made coronavirus vaccines.

Major state media outlets including Xinhua, People’s Daily, and China Daily churned out articles about the deaths of elderly Pfizer vaccine recipients in Norway and accused Western media of downplaying the deaths, even though multiple outlets have reported on them and Norwegian authorities explained that there was no evidence linking the deaths to the vaccine.

Liu Xin, a prominent Chinese state media anchor, shared an unverified report of 10 deaths in Germany, allegedly a result of receiving the Pfizer vaccine. Liu’s tweet was shared by Zhao Lijian, a spokesperson for the Chinese foreign ministry and one of the loudest nationalistic voices on Twitter, which remains banned inside China.

A new report by the social media research firm Graphika also uncovered a massive, clandestine, and increasingly sophisticated pro-Beijing digital disinformation network that has been spreading vaccine propaganda on YouTube, Twitter, and Facebook. While it is difficult to attribute the network to a particular government since the platforms allow a degree of anonymity, the campaign’s timing and messaging have been closely aligned with that of Chinese state media.

Beijing is playing a dangerous game. To scare people off from taking vaccines – by not disclosing data on the safety of its new vaccines and discrediting others’ vaccines – is only going to prolong the pandemic. This is something that no one, least of all Chinese authorities, should want.
 

johnq

Senior Member
Joined
May 30, 2009
Messages
2,128
Likes
4,254
(OFFICIAL) UAE, Bahrain make Pfizer/BioNTech shot available to those who got Sinopharm vaccine
Abu Dhabi has offered the Sinopharm shot to the general public since December and started using the Pfizer/BioNTech vaccine in April. It has been offering third Sinopharm doses since at least last month after it was discovered the shot had not created enough antibodies for some recipients.
There have been concerns about the efficacy of the Sinopharm vaccine, granted emergency approval by the World Health Organisation (WHO) in May, due to limited published clinical data being available.
 

johnq

Senior Member
Joined
May 30, 2009
Messages
2,128
Likes
4,254
Worries Grow Over China’s Sinopharm Covid Shot: Bahrain Plans Pfizer Booster For Fully Vaccinated People
Concerns over the effectiveness of Sinopharm’s vaccine continue to grow after Bahrain, battling a devastating coronavirus surge despite being one of the world’s most vaccinated nations, announced its decision to offer booster shots of the Pfizer-BioNTech vaccine for those already fully immunized with the Chinese-made vaccine Thursday, the latest in a string of setbacks for the state-owned vaccine recently authorized by WHO.

Key Facts

Vulnerable individuals—including those who are obese, over 50 or have long-term illnesses—are being urged get a Pfizer booster shot six months after receiving their last Sinopharm inoculation, reported the Wall Street Journal.

While a government spokesperson told Forbes the vaccine offers a similarly high level of protection as other vaccines, the policy change comes after the country already started offering Sinopharm boosters while battling a Covid surge five times as deadly as India’s despite having around 50% of its population fully vaccinated.

Several other highly vaccinated countries that deployed the Sinopharm shot heavily are also experiencing severe outbreaks, with the UAE and the Seychelles both considering or implementing booster programs of their own.

Global concerns surrounding the efficacy of Chinese-made vaccines—notably Sinopharm and Sinovac, which have both been granted emergency authorization by the WHO—have festered due to a lack of public clinical data needed to verify manufacturers’ claims, deficiencies in the data that is made available and the widespread politicization of vaccines.

The peer-reviewed study from Sinopharm’s Phase 3 trial, published at the end of May, found the vaccine to 79% effective at preventing symptomatic disease, but noted the predominantly young, healthy and male trial participants meant it had “insufficient power to test the efficacy among those with chronic diseases, women, (and) older adults,” a concern the WHO echoed for older people.

The study’s authors also noted that no conclusions could be drawn from the trial about the prevention of both severe and asymptomatic disease.

Sinopharm did not respond to Forbes’ request for comment on this story.

Crucial Quote

George Gao, the head of the Chinese Center for Disease Control and Prevention, acknowledged the poor efficacy of China’s vaccines at a conference in April, in what seemed to be an unintentional dissent from the party line. Gao said China was “formally considering” changes to its vaccines to “solve the problem that the efficacy of the existing vaccines is not high.” China responded swiftly, flushing discussion from social media and rebutting the incorrect interpretation of Gao’s statement. On state media, Gao later described it as a “misunderstanding.”

Big Number

90%. This is the proportion of cases in Bahrain that are attributed to people who have received no vaccine, a government spokesperson told Forbes.

Chief Critic

State-owned Sinopharm rarely addresses public concerns over efficacy. Chinese officials contend the line of questioning to be an example of anti-China bias and selective reporting ignoring deficiencies in other vaccines. Chinese Foreign Ministry spokesperson Hua Chunying said a Wall Street Journal article on the Seychelles “exposes their unhealthy mind-set of denigrating China at every turn.”

Key Background

China staunchly defends the quality and efficacy of its vaccines, which it rolled out long before completing late stage clinical trials, as an effective and needed tool to fight the pandemic, which it has used as a key foreign policy tool during the pandemic. Sinovac and Sinopharm’s vaccines are both in excess of the 50% efficacy threshold outlined by the WHO and FDA which, even at a lower limit, can have a major impact on saving lives in a world where the demand for vaccines continues to vastly outstrip demand. The use of another shot to boost immunity and fight new variants is also likely to be required of many Western vaccines—and major manufacturers are working on them—though it does not appear to be needed as soon as six months.

Surprising Fact

The UAE, which has been administering Sinopharm booster shots since March, has reportedly undertaken a clandestine effort to revaccinate fully vaccinated people with Pfizer’s shot. The Wall Street Journal cites “dozens of recipients” as telling them they have been vaccinated again, some of whom reported developing no antibodies after their Sinopharm immunization.
 

johnq

Senior Member
Joined
May 30, 2009
Messages
2,128
Likes
4,254
China’s great vaccine hope, Sinopharm, sees reputation darkened amid covid spikes in countries using it
Last year, Bahrain became one of the first countries to throw support behind China’s Sinopharm vaccine, granting it emergency use approval in December — a substantial boost for Beijing’s global ambitions for the vaccine, despite doubts on the part of some scientists over lack of public safety and efficacy data.

Now, the Persian Gulf country is the latest to raise doubts about the vaccine’s effectiveness.
Bahraini officials told news outlets this week that it would be offering Pfizer-BioNTech doses to certain high-risk individuals who have already received two Sinopharm jabs, suggesting they no longer saw two doses of the Sinopharm vaccine as enough, in the face of a new wave of coronavirus infections.

The policy comes just weeks after the World Health Organization granted Sinopharm emergency use listing, making it the first Chinese-developed vaccine to receive the global health body’s stamp of approval.

The vaccine, developed by Sinopharm with the Beijing Institute of Biological Products, makes up a significant chunk of China’s own supply of vaccines for domestic use. Though slow to start, China’s vaccination drive is ramping up, with officials suggesting 80 percent of the country could be immunized by the end of the year.
In Bahrain, however, a vaccination drive that relied heavily on Sinopharm has so far produced at best mixed results and failed to curb a rise in new cases.

Almost 50 percent of the country has been fully vaccinated, according to The Washington Post’s tracking, but the country has seen its worst wave of cases yet in the past few weeks, and the government has implemented a two-week lockdown in a bid to tame the outbreak.
According to the Bahrain News Agency, 1,936 new cases were reported on Thursday, bringing the total cases in the country of 1.6 million to more than 240,000, with over a thousand deaths.

Waleed Khalifa al-Manea, Bahrain’s undersecretary of health, told the Wall Street Journal in an article published Thursday that people fully vaccinated with Sinopharm who are over 50, with chronic illnesses or obese are being urged to get a booster of Pfizer-BioNTech six months after their last Sinopharm shot.

Bahrain and neighboring United Arab Emirates — which also relied heavily on Sinopharm for their rapid vaccine rollouts — had previously announced they would offer third-dose Sinopharm booster shots starting in mid-May, after studies showed that some of those vaccinated had not developed sufficient antibodies.
In Bahrain, residents can use an app to book their booster shots. Though they can choose either Sinopharm or Pfizer-BioNTech doses, those who meet certain risk groups would be advised to get the latter.

Sinopharm representatives did not respond to a request for comment.
Why the world’s most vaccinated country is seeing an unprecedented spike in coronavirus cases
The Gulf nation isn’t the only place where vaccine rollout has coincided with large waves of cases. In the Seychelles, Chile and Uruguay, all of whom have used Sinopharm or another Chinese vaccine called Sinovac in their mass vaccination efforts, cases have surged even as doses were given out.

A surge in infections in the Seychelles provided a “critical case to consider the effectiveness of some vaccines and what range we have to reach to meet herd immunity,” Yanzhong Huang, a senior fellow for global health at the Council on Foreign Relation, told The Washington Post at the time.
A WHO panel report last month found Sinopharm had a 79 percent efficacy rate in stopping symptomatic covid-19 in adults between 18 and 59, citing evidence from clinical trials in China, Bahrain, Egypt, Jordan and the United Arab Emirates.

While that efficacy was in the same range as that of a vaccine produced by AstraZeneca, it was considerably lower than that of the Pfizer-BioNTech and Moderna vaccines, which have reported efficacy of more than 90 percent.

Unlike those vaccines, which use new mRNA technology to train the immune system using a snippet of virus code, Sinopharm’s uses an inactivated version of the virus to do the same — an older, though well-established, technology.
The WHO panel also cautioned that it had a “low level of confidence” in the vaccine’s efficacy in people 60 and older, and a “very low confidence” about potential side effects in that age group, due to a lack of data.
Despite the concern about Sinopharm’s effectiveness, experts say the vaccine still works as intended in most cases and that it could play a significant role in shortages of vaccine doses around the world.

This week, millions of Sinopharm doses rolled off the production line in Beijing, intended to play a major role in the United Nations-backed vaccine sharing program Covax, amid persistent shortages. Sinopharm officials said Wednesday they hope to distribute more than 1 billion doses outside of China in the second half of 2020.

Separately, the WHO granted emergency use listing to another Chinese vaccine developed by Sinovac this week, reporting that the vaccine prevented symptomatic disease in 51 percent of those vaccinated and prevented severe cases in 100 percent of the population.
However, officials said there was not enough data to estimate the Sinovac vaccine’s efficacy in those over 60.
 

Latest Replies

Global Defence

New threads

Articles

Top